ESC 365 - Doctor Anna Drohomirecka

Speaker illustration

Doctor Anna Drohomirecka

National Institute of Cardiology, Warsaw (Poland)

Characteristics of heart failure patients treated in primary care - a 20-year perspective of real-world data.

Event: Heart Failure 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Frailty and biomarkers in heart failure

Sacubitril/valsartan dose escalation in a patient with low blood pressure and a history of orthostatic syncope under controlled remote monitoring of vital signs

Event: Heart Failure 2025

Topic: Clinical

Session: Effecting one’s future treatment in chronic heart failure

Exercise-induced proteomic profile changes in patients with advanced heart failure - a pilot study

Event: Heart Failure 2024

Topic: Pathophysiology

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 1

Changes of L-arginine and its derivatives in response to exercise test in patients with advanced heart failure

Event: Heart Failure 2022

Topic: Biomarkers

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

TAPSE as a simple echocardiographic parameter predicting exercise capacity in patients with advanced heart failure

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Right ventricular function

Session: Right ventricular function

Near infrared radiation attenuates platelets destruction during cardiopulmonary bypass -observations in an animal model

Event: ESC Congress 2016

Topic: Circulatory assist and other

Session: Assist devices and more

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources